MAPRE1P2: A Potential Drug Target and Biomarker (G642305)

Target Name: MAPRE1P2

NCBI ID: G642305

MAPRE1P2

Other Name(s): MAPRE1 pseudogene 2

MAPRE1P2: A Potential Drug Target and Biomarker

MAPRE1P2, also known as MAPRE1P2 gene or P2-100, is a gene located on chromosome 16q24. It has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases.

MAPRE1P2 is a gene that encodes a protein known as PD-L1, which is a known regulator of immune responses. The PD-L1 protein has been shown to play a crucial role in the regulation of T cell responses, and is often aberrantly expressed in various diseases, including cancer.

Research has also suggested that MAPRE1P2 may be involved in the regulation of pain perception and neuroinflammation.MAPRE1P2 has been shown to be highly expressed in the central nervous system and has been implicated in the pathophysiology of various neurological disorders, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis.

In addition to its potential clinical applications, MAPRE1P2 has also been identified as a potential biomarker for several diseases. For example, it has been shown to be highly expressed in the blood of patients with cancer, and may be a useful biomarker for monitoring disease progression and response to treatment.

MAPRE1P2 has also been shown to be involved in the regulation of stem cell proliferation and differentiation. This suggests that it may be a potential target for drugs that are aimed at inhibiting cancer cell growth and proliferation.

In conclusion, MAPRE1P2 is a gene that has the potential to be a drug target and biomarker for a variety of diseases. Further research is needed to fully understand its role in the regulation of immune responses, pain perception, and neuroinflammation, as well as its potential as a biomarker for disease.

Protein Name: MAPRE1 Pseudogene 2

The "MAPRE1P2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MAPRE1P2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets